The Genomics in Cancer Care Market reached USD 13.4 billion in 2022 and is projected to grow to USD 51.1 billion by 2031, exhibiting a CAGR of 18.9% during the forecast period 2024–2031, driven by the growing role of precision medicine and targeted therapies in oncology. Genomic testing helps identify cancer-causing mutations, such as BRCA1 and BRCA2, enabling accurate diagnosis,...
The global Liquid Biopsy Market is projected to expand from USD 3.8 billion in 2023 to USD 9.4 billion by 2032, growing at a robust CAGR of 10.7% during the forecast period (2024–2032). This rapid growth is fueled by increasing demand for non-invasive diagnostic methods, rising cancer incidence globally, and expanding applications of precision oncology.
Liquid biopsy is transforming...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek